LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 0 | 0 | 8,125 | 0 | 0 |
| Gross Profit | N/A | N/A | 8,125 | N/A | N/A |
| Operating Expenses | 2,274 | 3,928 | 16,769 | 63,537 | 55,693 |
| Operating Income | -2,274 | -3,928 | -8,644 | -63,537 | -55,693 |
| Interest Expense | 0 | 0 | 0 | 96 | 82 |
| Other Income | -9,274 | 168 | 10 | 779 | 2,699 |
| Pre-tax Income | -11,548 | -3,760 | -8,634 | -62,854 | -53,076 |
| Net Income Continuous | -11,548 | -3,760 | -8,634 | -62,854 | -53,076 |
| Net Income | $-11,548 | $-3,760 | $-8,634 | $-62,854 | $-53,076 |
| EPS Basic Total Ops | -1,579.50 | -250.00 | -0.14 | -1.26 | -1.40 |
| EPS Basic Continuous Ops | -1,564.77 | -225.96 | -0.14 | -1.26 | -1.40 |
| EPS Diluted Total Ops | -1,579.50 | -250.00 | -0.14 | -1.26 | -1.40 |
| EPS Diluted Continuous Ops | -1,564.77 | -225.96 | -0.14 | -1.26 | -1.40 |
| EBITDA(a) | $-2,274 | $-3,928 | $-8,527 | $-62,307 | $-54,233 |